Abstract:OBJECTIVE: Pharmaceutical companies often use drug samples as a marketing strategy in the ambulatory care setting. Little is known about how the availability of drug samples affects physicians' prescribing practices. Our goal was to assess: (1) under what circumstances and why physicians dispense drug samples, (2) if drug samples lead physicians to use medications other than their preferred drug choice, and (3) the physician characteristics that are associated with drug sample use.
DESIGN:Cross-sectional surve… Show more
“…Many reasons are given for physicians distributing drug samples rather than writing prescriptions that would necessitate a visit to the pharmacy. [9][10][11][12] According to physicians and other individuals polled (e.g., medical residents, nurses, pharmacists, participants in medical continuing education, pharmaceutical sale representatives), samples save the patient from having to go to the drugstore; reduce the cost of treatment; allow the patient to gain access to new treatments while allowing the physician to develop clinical experience and use new drugs that may not yet be covered by public or private plans; allow rapid initiation of therapy, which may be needed for clinical reasons; and allow the physician to verify short-term tolerance or efficacy before writing a prescription for the usual duration of therapy. The use of samples may even increase the patient's level of satisfaction.…”
Section: Discussionmentioning
confidence: 99%
“…[9][10][11][13][14][15] For example, the distribution of drug samples may jeopardize the continuity of care, especially as the patient's medication record at the retail pharmacy will be incomplete and the pharmacist is unlikely to meet the patient during the course of therapy with drug samples. These omissions can lead to unintended therapeutic duplication, allergic reactions, intolerances or interactions, doses that are too low or too high, use of contraindicated drugs, and missed opportunities to counsel patients.…”
Background: Few data exist on the presence of drug samples in health care facilities. Although the use of drug samples has potential benefits, this practice is also controversial, as it can contribute to non-optimal drug use. The objective of this study was to evaluate the inventory of drug samples in a health care institution and to determine compliance with existing policies and procedures.
“…Many reasons are given for physicians distributing drug samples rather than writing prescriptions that would necessitate a visit to the pharmacy. [9][10][11][12] According to physicians and other individuals polled (e.g., medical residents, nurses, pharmacists, participants in medical continuing education, pharmaceutical sale representatives), samples save the patient from having to go to the drugstore; reduce the cost of treatment; allow the patient to gain access to new treatments while allowing the physician to develop clinical experience and use new drugs that may not yet be covered by public or private plans; allow rapid initiation of therapy, which may be needed for clinical reasons; and allow the physician to verify short-term tolerance or efficacy before writing a prescription for the usual duration of therapy. The use of samples may even increase the patient's level of satisfaction.…”
Section: Discussionmentioning
confidence: 99%
“…[9][10][11][13][14][15] For example, the distribution of drug samples may jeopardize the continuity of care, especially as the patient's medication record at the retail pharmacy will be incomplete and the pharmacist is unlikely to meet the patient during the course of therapy with drug samples. These omissions can lead to unintended therapeutic duplication, allergic reactions, intolerances or interactions, doses that are too low or too high, use of contraindicated drugs, and missed opportunities to counsel patients.…”
Background: Few data exist on the presence of drug samples in health care facilities. Although the use of drug samples has potential benefits, this practice is also controversial, as it can contribute to non-optimal drug use. The objective of this study was to evaluate the inventory of drug samples in a health care institution and to determine compliance with existing policies and procedures.
“…Some argue that samples lead to overuse of expensive, brandname, medications in lieu of less expensive, evidence-based, treatments. 4 Despite these limitations, we found that 78% of elderly Medicare beneficiaries with CRN accessed free samples. We argue that the needs of these patients should be considered when adopting policies limiting free sample distribution.…”
T he authors reply: We agree with Zipkin that free prescription drug samples will not solve the problem of cost-related medication nonadherence (CRN). However, we argue that use of free prescription drug samples is widespread and indicative of physician attempts to increase economic access to medications.Our previous study demonstrated that 29% of disabled and 13% of elderly Medicare beneficiaries reported CRN. 1 It is therefore not surprising that our study and other investigations have found that physicians often provide samples to patients burdened by prescription costs. 2,3 Important questions remain: 1) what is the effect of policies restricting free samples on patient's prescription drug utilization, expenditures, and health outcomes; and 2) are samples a cost-driver or safety net? We acknowledge our inability in this study to discern the mechanism explaining the strong association between CRN and free sample use because of the cross-sectional design of the study. Some argue that samples lead to overuse of expensive, brandname, medications in lieu of less expensive, evidence-based, treatments. 4 Despite these limitations, we found that 78% of elderly Medicare beneficiaries with CRN accessed free samples. We argue that the needs of these patients should be considered when adopting policies limiting free sample distribution.Physicians need to recognize that requests for free samples are a marker of possible CRN that requires further investigation. Indeed, Piette et al. found that most patients are reluctant to report CRN and most physicians do not ask about affordability. 5 Rather than offering free samples, physicians can switch patients to generic drugs, discontinue nonessential medicines, or refer patients to programs providing financial assistance.For physicians who continue to distribute free samples, we recommend training on the influence of samples and other marketing devices. 6 Many physicians do not believe free samples influence prescribing. We recommend that medical licensing boards adopt policies requiring at least 1 hour of continuing medical education on the marketing of medications as a condition of license renewal for all prescribers. In this way, we might be able to effectively disseminate the message to all physicians that a "free sample" is not necessarily free.
“…The most useful research in this direction is probably the sparse literature in medicine that examines the motives of physicians while dispensing free samples to the patients. Such motives could emanate from factors such as: (1) financial savings; (2) convenience; (3) immediate initiation of therapy (4) demonstrating appropriate use of drugs; (5) adjustment of doses; (6) evaluating effectiveness of adverse effects of drugs (Chew, et al, 2000;Duffy and Clark, 2003) Studies (Gönül et al, 2001) have revealed that detailing has a positive and significant effect on doctors prescription of specific brand of drugs. Others find that detailing has a very modest effect (Mizik and Jacobson, 2004) or no effect at all (Rosenthal et al, 2003) on brand prescriptions or sales ( Leeflang et al, 2004) pointed that the incongruent effects of detailing are mainly due to the marketing expenditure made by the firms across different brands.…”
Section: Effects Of Pharmaceutical Crm On the Prescription Generationmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.